Ingredion (INGR) insider plans $109k stock sale under Form 144

Rhea-AI Filing Summary

Ingredion Inc. (INGR) – Form 144 filing: Director/officer Larry Fernandes has filed notice of intent to sell 850 common shares through Fidelity Brokerage on or after 04 Aug 2025. At the stated aggregate market value of $109,131.50, the implied share price is roughly $128.39. The proposed sale represents less than 0.002% of the 64.3 million shares outstanding and therefore is immaterial to the company’s float.

The shares were acquired via restricted-stock vesting on 11 Feb 2025; no cash was paid because the grant was compensation. In the preceding three months Fernandes sold 360 shares for $49,330.80 (≈ $137.03 per share). No other sales are disclosed in the notice. By signing the form, the filer affirms no undisclosed material adverse information and acknowledges Rule 10b5-1 obligations.

While insider sales can occasionally foreshadow sentiment shifts, the low volume and routine nature of this transaction suggest minimal market impact. Investors may nevertheless monitor future filings for any acceleration in selling activity.

Positive

• Transparency: Insider followed disclosure rules, indicating adherence to compliance procedures.
• Immaterial size: 850 shares (<0.002% of float) limits dilution and price impact.

Negative

• Insider selling signal: Continued disposals (1,210 shares in 3 months) may prompt sentiment concerns, albeit minor.

Insights

Corporate Governance Expert

TL;DR: Small, routine insider sale; negligible dilution, modest signaling risk.

The Form 144 reveals a prospective sale of 850 INGR shares by insider Larry Fernandes, worth about $0.11 million. Combined with 360 shares sold in May, total disposals equal 1,210 shares, still below 0.002% of outstanding stock. Such transactions are commonly driven by diversification or tax planning after restricted-stock vesting. Because the notice lacks any 10b5-1 plan reference, this could be discretionary; however, the quantity is too small to indicate a strategic exit. From a governance standpoint, transparency is intact and no adverse information is alleged. I classify the impact as neutral.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	850	109131.50	64311010	08/04/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/11/2025	Restricted Stock Vesting	Issuer			850	02/11/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Larry Fernandes 5 Westbrook Corporate Center Westchester IL 60154	Common	05/07/2025	360	49330.80

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Ingredion (INGR) shares are insiders proposing to sell?

The Form 144 covers a planned sale of 850 common shares.

What is the aggregate market value of the proposed INGR sale?

The filing lists an aggregate value of $109,131.50 for the 850 shares.

When can the INGR shares be sold under this Form 144?

The approximate sale date disclosed is 04 August 2025.

How many INGR shares did the insider sell in the past three months?

The insider sold 360 shares on 07 May 2025 for $49,330.80.

What percentage of INGR’s outstanding shares does the proposed sale represent?

About 0.002% of the 64.3 million shares outstanding.

How were the shares originally acquired?

They vested as restricted-stock compensation on 11 Feb 2025; no cash purchase was involved.